The current knowledge on proteomic biomarker analysis for the early diagnosis of lung
cancer is summarized, underlining the diversity among the results and the current interest in …

In the past decades, great progress has been made for the prevention and treatment of lung
cancer. Yet, lung cancer remains as the leading cause of cancer death worldwide. In this …

Lung cancer is the leading cause of cancer-related mortality across the globe. The most
prevalent pathological form of lung cancer is non-small-cell lung cancer (NSCLC). Elevated …

Background Lung cancer, especially lung squamous cell carcinoma (LUSC), is one of the
most common malignant tumors worldwide. Currently, radiosensitization research is a vital …

Introduction small-cell lung cancer (SCLC) is one of the most lethal malignancies. Its
management is complex due to the lack of biomarkers and limited therapies. Galectin-1 (Gal …

Long noncoding RNAs (lncRNAs) have been confirmed to be strongly associated with the
progression of various types of cancer. LncRNA LINC01234 (LINC01234) is a newly …

Background: EGFR mutations are present in approximately 15–50% of non-small cell lung
cancer (NSCLC), which are predictive of anti-EGFR therapies. At variance, NSCLC patients …

Lung adenocarcinoma (LUAD) is one of the leading causes of cancer death globally. This
study aims to investigate the underlying mechanisms implicated with LUAD and identify the …

Non-small cell lung cancer (NSCLC) is a common malignant subtype of lung cancer with
high mortality. Resveratrol (RSV) is a natural molecule that regulates mitochondrial …

Background To systematically assess the consistency of recommendations regarding
diagnosis and treatment of non-small cell lung cancer (NSCLC) in clinical practice …